<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04334681</url>
  </required_header>
  <id_info>
    <org_study_id>pilonidal surgery group</org_study_id>
    <nct_id>NCT04334681</nct_id>
  </id_info>
  <brief_title>Comparison of Un-roofing Curettage With Rhomboid Excision and Modified Limberg Flap</brief_title>
  <official_title>Comparison of Un-roofing Curettage With Rhomboid Excision and Modified Limberg Flap in the Surgical Treatment of Pilonidal Disease; A Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konya Meram State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konya Meram State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In our hospital, between January 2013 and January 2017, those operated with the Modified&#xD;
      Limberg flap method after the Rhomboid excision due to pilonidal disease, and those operated&#xD;
      with the un-roofing curettage method will be screened retrospectively. Patients will be&#xD;
      divided into two groups as Un-roofing curettage group (UC group) and the Modified Limberg&#xD;
      Flap group (LF group). Operation time, hospital stay time, return to work time, recovery&#xD;
      time, Time to walk without pain, days, Time to sit on the toilet without pain, days,&#xD;
      Postoperative VAS and recurrence will be compared between both groups&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In our hospital, between January 2013 and January 2017, those operated with the Modified&#xD;
      Limberg flap method after the Rhomboid excision due to pilonidal disease, and those operated&#xD;
      with the un-roofing curettage method will be screened retrospectively. Patients who are well&#xD;
      followed up will be included in the study. Demographic features will be recorded. Patients&#xD;
      will be divided into two groups, the un-roofing curettage group (UC group) and the Modified&#xD;
      Limberg Flap group (LF group). Surgery time, hospital stay, return to work time, recovery&#xD;
      time, painless walking time, days, painless sitting time in the toilet, days, postoperative&#xD;
      VAS, and recurrence will be compared between both groups. In addition, mobilization time,&#xD;
      days, recovery time, days, exclusion time, days, wound infection, wound distribution will be&#xD;
      compared between groups. The results will be analyzed with the SPSS statistics program.&#xD;
      Factors affecting recurrence wound infection, recovery time, hospital stay, operation time,&#xD;
      early mobilization will be evaluated by univariate and multivariate logistic regression&#xD;
      analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2020</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mobilization Time,Days</measure>
    <time_frame>15 days</time_frame>
    <description>Time to return to the daily activities of the patients were measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Recurring Disease</measure>
    <time_frame>Number of Participants with Recurring Disease, up to five years</time_frame>
    <description>It has been reported in the literature that a five or ten year follow-up period is required for the effective evaluation of recurrence. In both groups, the number of recurrent patients during the follow-up period will be determined.&#xD;
Observation of the following findings on physical examination made a diagnosis of recurrence;&#xD;
New sinus orifice formation,&#xD;
Or discharge from the sinus orifice</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Operation Time</measure>
    <time_frame>operation time, up to 100 minutes</time_frame>
    <description>Mean operation time was determined in minutes in both groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospitalization Time</measure>
    <time_frame>Hospitalization time, up to 15 days</time_frame>
    <description>In both groups, hospitalization will be determined as a day.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">278</enrollment>
  <condition>Pilonidal Disease</condition>
  <arm_group>
    <arm_group_label>UC Group</arm_group_label>
    <description>Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LF Group</arm_group_label>
    <description>Patients who have been operated with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Un-roofing curettage method</intervention_name>
    <description>In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
    <arm_group_label>UC Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified Limberg Flap Group</intervention_name>
    <description>In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.</description>
    <arm_group_label>LF Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Limberg flap after rhomboid excision and un-roofing curettage between January&#xD;
        2013 and January 2017 in our hospital constitute the study population.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between the ages of 18 and 70&#xD;
&#xD;
          -  Patients with sufficient registration information&#xD;
&#xD;
          -  Telephone-accessible patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under the age of 18&#xD;
&#xD;
          -  Patients over 70 years old&#xD;
&#xD;
          -  Common gluteal disease&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Connective tissue disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Konya Training and Research Hospital</name>
      <address>
        <city>Konya</city>
        <zip>42090</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Mahdy T. Surgical treatment of the pilonidal disease: primary closure or flap reconstruction after excision. Dis Colon Rectum. 2008 Dec;51(12):1816-22. doi: 10.1007/s10350-008-9436-8. Epub 2008 Oct 21.</citation>
    <PMID>18937009</PMID>
  </reference>
  <reference>
    <citation>Kepenekci I, Demirkan A, Celasin H, Gecim IE. Unroofing and curettage for the treatment of acute and chronic pilonidal disease. World J Surg. 2010 Jan;34(1):153-7. doi: 10.1007/s00268-009-0245-6.</citation>
    <PMID>19820992</PMID>
  </reference>
  <reference>
    <citation>Karakayali F, Karagulle E, Karabulut Z, Oksuz E, Moray G, Haberal M. Unroofing and marsupialization vs. rhomboid excision and Limberg flap in pilonidal disease: a prospective, randomized, clinical trial. Dis Colon Rectum. 2009 Mar;52(3):496-502. doi: 10.1007/DCR.0b013e31819a3ec0.</citation>
    <PMID>19333052</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 1, 2020</study_first_submitted>
  <study_first_submitted_qc>April 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2020</study_first_posted>
  <results_first_submitted>October 2, 2020</results_first_submitted>
  <results_first_submitted_qc>January 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 8, 2021</results_first_posted>
  <last_update_submitted>January 14, 2021</last_update_submitted>
  <last_update_submitted_qc>January 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konya Meram State Hospital</investigator_affiliation>
    <investigator_full_name>Alpaslan Şahin</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 4, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT04334681/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>When we planned to study, we estimated 200 patients. However, we reached 278 patient data and analyzed them.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>UC Group</title>
          <description>Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
        </group>
        <group group_id="P2">
          <title>LF Group</title>
          <description>Patients who have been operated with the Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the Limberg flap method.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="135"/>
                <participants group_id="P2" count="143"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="135"/>
                <participants group_id="P2" count="143"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>UC Group</title>
          <description>Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
        </group>
        <group group_id="B2">
          <title>LF Group</title>
          <description>Patients who have been operated with the Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the Limberg flap method.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="135"/>
            <count group_id="B2" value="143"/>
            <count group_id="B3" value="278"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="135"/>
                    <count group_id="B2" value="143"/>
                    <count group_id="B3" value="278"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.35" spread="8.9"/>
                    <measurement group_id="B2" value="26.42" spread="7.9"/>
                    <measurement group_id="B3" value="25.90" spread="8.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="135"/>
                    <count group_id="B2" value="143"/>
                    <count group_id="B3" value="278"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="115"/>
                    <measurement group_id="B2" value="127"/>
                    <measurement group_id="B3" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Turkey</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="135"/>
                    <count group_id="B2" value="143"/>
                    <count group_id="B3" value="278"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="135"/>
                    <measurement group_id="B2" value="143"/>
                    <measurement group_id="B3" value="278"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mobilization Time,Days</title>
        <description>Time to return to the daily activities of the patients were measured.</description>
        <time_frame>15 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>UC Group</title>
            <description>Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
          </group>
          <group group_id="O2">
            <title>MLF Group</title>
            <description>Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.</description>
          </group>
        </group_list>
        <measure>
          <title>Mobilization Time,Days</title>
          <description>Time to return to the daily activities of the patients were measured.</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.21" spread="3.7"/>
                    <measurement group_id="O2" value="12.3" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Recurring Disease</title>
        <description>It has been reported in the literature that a five or ten year follow-up period is required for the effective evaluation of recurrence. In both groups, the number of recurrent patients during the follow-up period will be determined.&#xD;
Observation of the following findings on physical examination made a diagnosis of recurrence;&#xD;
New sinus orifice formation,&#xD;
Or discharge from the sinus orifice</description>
        <time_frame>Number of Participants with Recurring Disease, up to five years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MLF Group</title>
            <description>Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.</description>
          </group>
          <group group_id="O2">
            <title>UC Group</title>
            <description>Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Recurring Disease</title>
          <description>It has been reported in the literature that a five or ten year follow-up period is required for the effective evaluation of recurrence. In both groups, the number of recurrent patients during the follow-up period will be determined.&#xD;
Observation of the following findings on physical examination made a diagnosis of recurrence;&#xD;
New sinus orifice formation,&#xD;
Or discharge from the sinus orifice</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Operation Time</title>
        <description>Mean operation time was determined in minutes in both groups.</description>
        <time_frame>operation time, up to 100 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>UC Group</title>
            <description>Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
          </group>
          <group group_id="O2">
            <title>MLF Group</title>
            <description>Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.</description>
          </group>
        </group_list>
        <measure>
          <title>Operation Time</title>
          <description>Mean operation time was determined in minutes in both groups.</description>
          <units>minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.44" spread="3.56"/>
                    <measurement group_id="O2" value="52.47" spread="7.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hospitalization Time</title>
        <description>In both groups, hospitalization will be determined as a day.</description>
        <time_frame>Hospitalization time, up to 15 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>UC Group</title>
            <description>Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
          </group>
          <group group_id="O2">
            <title>MLF Group</title>
            <description>Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalization Time</title>
          <description>In both groups, hospitalization will be determined as a day.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.45"/>
                    <measurement group_id="O2" value="1.07" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>UC Group</title>
          <description>Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Un-roofing curettage method: In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.</description>
        </group>
        <group group_id="E2">
          <title>LF Group</title>
          <description>Patients who have been operated with the Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.&#xD;
Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the Limberg flap method.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="143"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <description>Post-operative bleeding from the wound site</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="143"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <description>Postoperative hematoma (clotted blood accumulation) from the wound site</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="135"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Wound İnfection</sub_title>
                <description>wound infection development in the postoperative period</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="135"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="143"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <description>wound dehiscence in the postoperative period</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="135"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alpaslan Şahin</name_or_title>
      <organization>prinipal investigator</organization>
      <phone>0332310500 ext 50510</phone>
      <email>drasahin@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

